Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer

BACKGROUND: Data are sparse concerning the sequential use of multiple anaplastic lymphoma kinase (ALK) inhibitors for ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). OBJECTIVE: This study investigated sequencing and outcomes among patients receiving multiple ALK inhib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs Real World Outcomes
Autores principales: Waterhouse, David M., Espirito, Janet L., Chioda, Marc D., Baidoo, Bismark, Mardekian, Jack, Robert, Nicholas J., Masters, Elizabeth T.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581667/
https://ncbi.nlm.nih.gov/pubmed/32725539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-020-00207-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares